A conversation with Paul Marks. Interview by Ushma S. Neill.
作者信息
Marks Paul
出版信息
J Clin Invest. 2012 Oct;122(10):3371-2. doi: 10.1172/jci66190.
Abstract
摘要
相似文献
1
A conversation with Paul Marks. Interview by Ushma S. Neill.
J Clin Invest. 2012 Oct;122(10):3371-2. doi: 10.1172/jci66190.
2
A conversation with Harold Varmus. Interview by Ushma S. Neill.
J Clin Invest. 2012 Apr;122(4):1134-5. doi: 10.1172/jci63633.
3
Where does hematology end and oncology begin? Questions of professional boundaries and medical authority.
J Clin Oncol. 2006 Jun 1;24(16):2583-8. doi: 10.1200/JCO.2005.04.9510.
4
A conversation with Paul Greengard. Interview by Ushma S. Neill.
J Clin Invest. 2013 Mar;123(3):937-8. doi: 10.1172/JCI68877. Epub 2013 Mar 1.
5
Professor John M. Goldman, CML pioneer 1938-2013.
Int J Hematol. 2014 Feb;99(2):103-4. doi: 10.1007/s12185-014-1499-9.
6
History of pediatric hematology and oncology in Greece.
Pediatr Hematol Oncol. 1994 Jan-Feb;11(1):13-25. doi: 10.3109/08880019409141897.
7
[History of the Department of the Hematology and Oncology at the Children States Hospital, Kielce, Poland].
Med Wieku Rozwoj. 2006 Jul-Sep;10(3 Suppl 1):65-6.
8
Vorinostat approved for rare lymphoma.
Am J Health Syst Pharm. 2006 Nov 15;63(22):2168. doi: 10.2146/news060020.
9
[History of the Hematology and Children Oncology in Szczecin, Poland].
Med Wieku Rozwoj. 2006 Jul-Sep;10(3 Suppl 1):45-6.
10
[History of Hematology "Dzialdowski" - my own account].
Med Wieku Rozwoj. 2006 Jul-Sep;10(3 Suppl 1):87-9.
Zotero 插件